Coreline Soft Participates in the '2023 Korean Society of Medical Imaging Informatics Conference'

Coreline Soft, a medical artificial intelligence (AI) specialized company (CEO Jin-Kook Kim and Jung-Pil Choi), announced on the 6th that it will participate in the ‘37th Annual Conference of the Korean Society of Imaging Informatics in Medicine (KSIIM) 2023’.

This ‘Korean Society of Imaging Informatics in Medicine Annual Conference’ was organized to review the achievements and challenges of medical AI technology amid a turning point in AI technology and to discuss future directions. Experts from both industry and medical fields, who are prominent in the medical AI sector, will participate to introduce medical AI technologies and conduct in-depth discussions related to the industry. The ‘37th Annual Conference of the Korean Society of Imaging Informatics in Medicine 2023’ will be held over two days, from the 7th to the 8th, at Seoul St. Mary’s Hospital.

At this conference, Coreline Soft plans to showcase ‘AVIEW LCS PLUS,’ which automatically examines lung cancer, chronic obstructive pulmonary disease, cardiovascular disease, and more simultaneously with a single low-dose chest CT scan. Additionally, Coreline Soft’s CEO Jin-Kook Kim will participate as a panelist in the ‘Panel Discussion for Industry-Academy Collaboration’ as a medical AI industry representative.

Recently, Coreline Soft has been presenting its ‘AVIEW’ solutions at various touchpoints, supported by the growing interest in medical AI solutions. Prior to this exhibition, it participated in the ‘Korean Society for Radiation Oncology Annual Meeting’ to showcase the AI contouring solution of ‘AVIEW RT ACS.’ It also participated in the Asian Conference on Thoracic Imaging (ACTI 2023), an international academic conference, where it exhibited the ‘AVIEW’ solution and hosted a luncheon session inviting leading medical AI experts from Asia.

Coreline Soft CEO Jin-Kook Kim said, “Participating in this conference is a particularly meaningful opportunity to introduce our ‘AVIEW’ solution to medical AI experts from industry and medicine and to engage in in-depth discussions related to it.” He added, “Coreline Soft will continue to focus its capabilities on advancing technology and expanding touchpoints to meet the increasing demand and interest in medical AI.”

Meanwhile, as medical AI has established itself as a popular theme in the market, attracting attention to medical AI companies such as Lunit and VUNO, Coreline Soft has submitted a securities registration statement for a merger with ‘Shinhan No.7 SPAC’ to the Financial Services Commission for its full-scale KOSDAQ listing. It aims to be listed in September after going through processes such as a shareholders’ meeting for merger approval.

This content was produced with the assistance of AI translation services.